Nanomedicine for the prevention, treatment and imaging of atherosclerosis.

Nanomedicine for the prevention, treatment and imaging of atherosclerosis.

Näytä muut versiot (2)

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in developed countries, with an increasing prevalence due to an aging population. The pathology underpinning CVD is atherosclerosis, a chronic inflammatory state involving the arterial wall. Accumulation of low density lipo...

Bibliografiset tiedot
Päätekijät:	Psarros, C, Lee, R, Margaritis, M, Antoniades, C
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2012

Samankaltaisia teoksia

Nanomedicine for the prevention, treatment and imaging of atherosclerosis
Tekijä: Psarros, C, et al.
Julkaistu: (2012)

Nanomedicine for the prevention, treatment and imaging of atherosclerosis.
Tekijä: Psarros, C, et al.
Julkaistu: (2012)

Nanomedicine for Diagnosis and Treatment of Atherosclerosis
Tekijä: Jingyun Cheng, et al.
Julkaistu: (2023-12-01)

Construction of dual nanomedicines for the imaging and alleviation of atherosclerosis
Tekijä: Shuihua Zhang, et al.
Julkaistu: (2020-01-01)

The role of adiponectin at different stages of atherosclerosis in heart failure: associations with myocardial redox state
Tekijä: Antonopoulos, A, et al.
Julkaistu: (2010)

Nanomedicine-based drug delivery strategies for the treatment of atherosclerosis
Tekijä: Yongfang Lin, et al.
Julkaistu: (2024-06-01)

Nanoparticles: a promising therapeutic approach in atherosclerosis.
Tekijä: Antoniades, C, et al.
Julkaistu: (2010)

Biomimetic nanomedicines for precise atherosclerosis theranostics
Tekijä: Ying Tao, et al.
Julkaistu: (2023-11-01)

Editorial: Advances on targeted nanomedicines for atherosclerosis
Tekijä: Qinggong Han, et al.
Julkaistu: (2022-10-01)

Novel therapeutic strategies targeting vascular redox in human atherosclerosis.
Tekijä: Antonopoulos, A, et al.
Julkaistu: (2009)

Macrophage-targeted nanomedicine for the diagnosis and management of atherosclerosis
Tekijä: Ping Ping Hu, et al.
Julkaistu: (2022-09-01)

Advanced targeted nanomedicines for vulnerable atherosclerosis plaque imaging and their potential clinical implications
Tekijä: Xue Li, et al.
Julkaistu: (2022-10-01)

Statin treatment improves vascular redox state through a tetrahydrobiopterin-mediated re-coupling of endothelial nitric oxide synthase, in human atherosclerosis
Tekijä: Antoniades, C, et al.
Julkaistu: (2011)

Multifunctional phototheranostic nanomedicine for cancer imaging and treatment
Tekijä: D. Gao, et al.
Julkaistu: (2020-01-01)

Precision nanomedicine in atherosclerosis therapy: how far are we from reality?
Tekijä: Yee Shan Wong, et al.
Julkaistu: (2019-01-01)

Precision nanomedicine in atherosclerosis therapy: how far are we from reality?
Tekijä: Yee Shan Wong, et al.

Interrelationships between vascular superoxide and adiponectin biosynthesis in perivascular adipose tissue in human atherosclerosis
Tekijä: Bakogiannis, C, et al.
Julkaistu: (2010)

Shedding new light on atherosclerosis therapeutics: Nanomedicines targeting atherosclerotic immune microenvironment
Tekijä: Zhiyue Wang, et al.
Julkaistu: (2024-12-01)

Nanomedicine for renal cell carcinoma: imaging, treatment and beyond
Tekijä: Ruolin Wu, et al.
Julkaistu: (2023-01-01)

Adiponectin as a regulator of vascular redox state in human atherosclerosis
Tekijä: Margaritis, M
Julkaistu: (2016)

L-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis?
Tekijä: Siasos, G, et al.
Julkaistu: (2007)

A NOVEL CROSS-TALK BETWEEN PERIVASCULAR ADIPOSE TISSUE AND THE ARTERIAL WALL CONTROLS REDOX STATE IN HUMAN ATHEROSCLEROSIS
Tekijä: Margaritis, M, et al.
Julkaistu: (2013)

A novel cross-talk between perivascular adipose tissue and the arterial wall controls redox state in human atherosclerosis
Tekijä: Margaritis, M, et al.
Julkaistu: (2013)

Insulin-induced vascular redox dysregulation in human atherosclerosis is ameliorated by dipeptidyl peptidase 4 inhibition
Tekijä: Akoumianakis, I, et al.
Julkaistu: (2020)

Macrophage-targeting Antisenescence nanomedicine enables in-Situ NO induction for Gaseous and antioxidative atherosclerosis intervention
Tekijä: Yuanyuan Peng, et al.
Julkaistu: (2025-06-01)

Insulin Treatment Induces Oxidative Stress in the Vascular Wall of Patients With Atherosclerosis Independently of Diabetes or Systemic Insulin Resistance: The Protective Role of DPP-IV Inhibition
Tekijä: Akoumianakis, I, et al.
Julkaistu: (2018)

Statins in coronary artery bypass grafting surgery: lipid lowering and beyond.
Tekijä: Margaritis, M, et al.
Julkaistu: (2012)

Macrophage membrane-functionalized manganese dioxide nanomedicine for synergistic treatment of atherosclerosis by mitigating inflammatory storms and promoting cholesterol efflux
Tekijä: Sijin Chen, et al.
Julkaistu: (2024-10-01)

Biomarkers of premature atherosclerosis.
Tekijä: Kampoli, A, et al.
Julkaistu: (2009)

An immunoregulator nanomedicine approach for the treatment of tuberculosis
Tekijä: Luona Yang, et al.
Julkaistu: (2023-05-01)

Atorvastatin rapidly reduces myocardial superoxide and peroxynitrite generation in human atherosclerosis, by suppressing NADPH-oxidase activity independently of LDL lowering
Tekijä: Antoniades, C, et al.
Julkaistu: (2011)

Challenges to Safe Nanomedicine Treatment
Tekijä: Chunhua Yang, et al.
Julkaistu: (2023-03-01)

Nanomedicine: Engineering of a tri-imageable nanoparticle for diagnostics
Tekijä: Bumb, A, et al.
Julkaistu: (2009)

The role of perivascular fat in the diagnosis and prognosis of atherosclerosis
Tekijä: Polkinghorne, M, et al.
Julkaistu: (2022)

Homocysteine lowering: any use in atherosclerosis?
Tekijä: Antoniades, C, et al.
Julkaistu: (2007)

Perivascular adipose tissue and coronary atherosclerosis
Tekijä: Mancio, J, et al.
Julkaistu: (2018)

State-of-the-art review article. Atherosclerosis affecting fat: What can we learn by imaging perivascular adipose tissue?
Tekijä: Antoniades, C, et al.
Julkaistu: (2019)

Nanomedicine Explored at Molecular Imaging Summit
Tekijä: Julie L. Sutcliffe PhD
Julkaistu: (2011-01-01)

The Role of Optical Imaging in Translational Nanomedicine
Tekijä: Evelien Hesemans, et al.
Julkaistu: (2022-08-01)

Advances in nanomedicines for lymphatic imaging and therapy
Tekijä: Pan He, et al.
Julkaistu: (2023-08-01)